HealthDay - MONDAY, Aug. 3 (HealthDay News) -- Invega Sustenna (paliperidone palmitate) has been approved by the U.S. Food and Drug Administration to treat schizophrenia, drug maker Janssen said in a news release.
Read the full article...
(From Yahoo Diseases)